orangebookcompanion.com

What It Is

Orange Book Companion is an enhanced FDA Orange Book information service from Blazing Dawn Software, focused on drug patents, exclusivity periods, patent expirations, and historical archive research. It is not general-purpose enterprise software, but a highly specialized pharmaceutical regulatory and patent intelligence tool designed to make Orange Book searches faster and more efficient.

Core Features and Data Coverage

The product covers drug patent expirations, patent family information, patent titles, claim types, drug categories, and provides hyperlinks to USPTO patent pages and FDA information. Its Orange Book Archive includes expired Orange Book patent and exclusivity information from the early Hatch-Waxman era through the end of 2023, and can be browsed by brand name, generic name, patent number, and other fields. The site also indicates that it tracks FTC dispute correspondence related to certain Orange Book patents, making it useful for generic drug project selection, patent portfolio review, and regulatory intelligence analysis.

Pricing, Trial, and Deployment

An OBC Online subscription costs $295/year and covers the entire company; new subscriptions come with a 30-day money-back guarantee. The website also mentions options such as a Flash Drive monthly subscription and a two-volume book with monthly updates, but does not disclose full pricing. Deployment is primarily online access. Flash Drive content may be copied to a single intranet server or a single device, reflecting a more traditional information-product model.

Collaboration, Security, and Integrations

Access rules are relatively basic: employees and contractors on the same company intranet may use the account, and remote access is also allowed, but sharing outside the company is prohibited. No role-based permissions, SSO, audit logs, API, or developer documentation were found. On security and compliance, the terms mainly focus on copyright and distribution restrictions, with no disclosed enterprise-grade security details such as encryption, SLA, or compliance certifications. Third-party integration is mainly limited to links to FDA and USPTO resources rather than system-level integrations.

Pros, Cons, and Who It’s For

Its strengths are deep domain focus, low pricing, historical data coverage, and publicly available samples that do not require a subscription. Its drawbacks are a traditional interface and interaction model, along with limited automation and enterprise SaaS capabilities. It is suitable for pharmaceutical companies, generic drug manufacturers, IP lawyers, regulatory affairs teams, and drug patent researchers. The source material does not make it possible to determine accessibility from China; payment involves 2Checkout, so users in China should confirm credit card and network availability. Alternatives include FDA Electronic Orange Book, USPTO Patent Public Search, or larger commercial drug patent databases.